Year | Volume (Price x Shares) | Change |
---|---|---|
2024 | $46.88 M | 926.08% |
2023 | $4.56 M | -72.01% |
2022 | $16.32 M | -44.51% |
2021 | $29.41 M | -63.07% |
2020 | $79.64 M | 122.76% |
2019 | $35.75 M | -46% |
2018 | $66.21 M | -54.43% |
2017 | $0.14 B | -47.42% |
2016 | $0.27 B | 9.96% |
2015 | $0.25 B | -37.28% |
2014 | $0.40 B | 16.96% |
2013 | $0.34 B |
Company | FTD volume (3months) | FTD volume (1 year) | Country |
---|---|---|---|
Johnson & Johnson JNJ | $28.5 M | $0.59 B | ๐บ๐ธ USA |
Abbott Laboratories ABT | $14.63 M | $0.13 B | ๐บ๐ธ USA |
Regeneron Pharmaceuticals REGN | $0.8 M | $0.14 B | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $0.23 B | $0.33 B | ๐บ๐ธ USA |
LabCorp LH | $0.01 M | $48.3 M | ๐บ๐ธ USA |
Alnylam Pharmaceuticals
ALNY | $3.16 M | $37.95 M | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $0.84 M | $25.76 M | ๐ฎ๐ฑ Israel |
Ardelyx ARDX | $3.95 M | $30.45 M | ๐บ๐ธ USA |